ESC 365 - Low-dose colchicine in patients treated with percutaneous coronary interventions for myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)

ESC Premium Access

Low-dose colchicine in patients treated with percutaneous coronary interventions for myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)

Session: Deep Dive in Acute Coronary Syndromes

Topic: Inflammation

Speaker: Professor P. L'Allier (Montreal, CA)

Event: ESC Congress 2020

Congress Presentation

About the speaker

Professor Philippe L'Allier

Montreal Heart Institute, Montreal (Canada)

0 follower

2 more presentations in this session

Diagnostic impact of early cardiac magnetic resonance imaging in patients with the working diagnosis of MINOCA. Does the final diagnosis affect patients outcome?

Speaker: Doctor H. Vago (Budapest, HU)

The Gly82Ser polymorphism in the receptor for advanced glycation end products is associated with increased risk for coronary events in the general population

Speaker: Mrs H. Grauen Larsen (Malmo, SE)

Access the full session

Deep Dive in Acute Coronary Syndromes

Speakers: Professor P. L'Allier, Doctor H. Vago, Mrs H. Grauen Larsen

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

ESC 365 is supported by